Vaginal Photobiomodulation for Chronic Pelvic Pain
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18+
SponsorSoLa Pelvic Therapy
About this trial
The goal of this clinical study is to determine if 8 treatments with photobiomodulation using near-infrared laser energy can help reduce chronic pelvic pain in women. Additionally, researchers want to determine if treatment with this type of energy can also alleviate pain with activities such as standing, sitting, urinating, having bowel movements and intercourse.
Eligibility criteria
Qualifiers
Age 18 years or older;
CPP for 3 months or longer;
Overall pelvic pain severity ≥4 in the last 7 days;
Pelvic muscle tenderness pain level ≥4.
Disqualifiers
Previous vaginal or vulvar laser therapy;
Receiving concurrent pelvic physical therapy;
Unable to tolerate vaginal/pelvic examination
Taking drugs that have heat- or light- sensitive contraindications;
Trial design
Treatments tested in this trial
- SoLa Pelvic Therapy
Treatment groups
126 Participants
are divided into 2 treatment groupsLocations
5Obgyn South35209, BirminghamAlabama, United States
The Orady Womens Clinic94109, San FranciscoCalifornia, United States
Urogynecology of Kansas City66214, Overland ParkKansas, United States
Boston Urogyn02481, BostonMassachusetts, United States
Sponsors and collaborators
SoLa Pelvic Therapy
Lead sponsor
Uroshape LLC
Collaborator
Source ClinicalTrials.gov